BDBM693128 4-(4-((1R,5S)-3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2-methylenetetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol::US20240270758, Example Z3
SMILES Oc1cc(-c2ncc3c(nc(OCC45CCCN4CC(=C)C5)nc3c2F)N2CC3CCC(C2)N3)c2c(C#C)c(F)ccc2c1
InChI Key InChIKey=REDSBIDCOJPLJV-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 693128
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Genfleet Therapeutics (Shanghai)
US Patent
Genfleet Therapeutics (Shanghai)
US Patent
Affinity DataIC50: 16.2nMAssay Description:This experiment is intended to investigate the inhibitory effect of compounds on the binding of KRASG12D mutant protein or KRASWt (wild type) protein...More data for this Ligand-Target Pair
Ligand InfoSimilars
TargetGTPase KRas/RAF proto-oncogene serine/threonine-protein kinase(Human)
Genfleet Therapeutics (Shanghai)
US Patent
Genfleet Therapeutics (Shanghai)
US Patent
Ligand InfoSimilars